Iowa Senate Bill SF319

Iowa 2023-2024 Regular Session

• Introduced: 2/16/23
• Engrossed: 3/14/23
• Refer: 5/4/23

Caption

A bill for an act concerning private sector employee drug testing.(Formerly SSB 1141.)

Impact

The bill amends Code section 730.5, which governs drug testing in Iowa's private sector, particularly addressing the burdens of proof in legal cases involving drug testing. Under the amended provisions, an employer who violates the drug testing regulations can be subject to civil remedies. This includes affirmative relief that could be awarded to aggrieved employees, such as reinstatement or compensation for damages, thereby reinforcing protections for workers against unfair testing practices. Furthermore, employers will now have the burden of proof if a drug test is challenged in court.

Summary

Senate File 319 is a legislative proposal focused on modifying existing laws regarding private sector employee drug testing. The bill was introduced by the Committee on Workforce as a successor to SSB 1141. A key aspect of the proposal is the redefinition and clarification of 'safety-sensitive positions,' aimed at providing employers with more authority to designate which positions fall under stricter testing protocols. This change underlines the importance of workplace safety and the need for clear regulations in jobs that have significant safety implications.

Contention

The modifications proposed in SF319 have sparked debate among lawmakers and advocacy groups. Proponents argue that these changes will enhance workplace safety and accountability by allowing employers to enforce drug testing more strictly within designated safety-sensitive roles. However, opponents express concerns that altering the burden of proof may lead to potential misuse and wrongful disciplinary actions against employees, compromising their rights and job security. The debate reflects a broader conversation about balancing workplace safety with individual rights in drug testing scenarios.